ClinVar Miner

Submissions for variant NM_006949.4(STXBP2):c.1586G>A (p.Arg529Gln)

dbSNP: rs35490401
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000814223 SCV000954624 likely benign Familial hemophagocytic lymphohistiocytosis 5 2025-01-17 criteria provided, single submitter clinical testing
Baylor Genetics RCV000814223 SCV001530599 uncertain significance Familial hemophagocytic lymphohistiocytosis 5 2018-04-14 criteria provided, single submitter clinical testing This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868].
Mayo Clinic Laboratories, Mayo Clinic RCV001507407 SCV001712947 uncertain significance not provided 2019-09-16 criteria provided, single submitter clinical testing
Ambry Genetics RCV002538187 SCV003634939 uncertain significance Inborn genetic diseases 2021-09-27 criteria provided, single submitter clinical testing The c.1586G>A (p.R529Q) alteration is located in exon 18 (coding exon 18) of the STXBP2 gene. This alteration results from a G to A substitution at nucleotide position 1586, causing the arginine (R) at amino acid position 529 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.